BAYRY - Bayer Aktiengesellschaft

Other OTC - Other OTC Delayed Price. Currency in USD
17.96
-0.29 (-1.59%)
As of 11:21AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close18.25
Open18.06
Bid0.00 x 0
Ask0.00 x 0
Day's Range17.85 - 18.09
52 Week Range17.85 - 33.86
Volume179,631
Avg. Volume1,313,707
Market Cap66.402B
Beta (3Y Monthly)1.30
PE Ratio (TTM)8.06
EPS (TTM)2.23
Earnings DateN/A
Forward Dividend & Yield0.81 (4.03%)
Ex-Dividend Date2018-05-25
1y Target Est35.33
Trade prices are not sourced from all markets
  • Bayer profit flat as weak animal health offsets strong Xarelto
    Reuters Videos2 days ago

    Bayer profit flat as weak animal health offsets strong Xarelto

    Bayer's adjusted core earnings were flat for the quarter, as better prescription numbers for cardiovascular drug Xarelto were tempered by a weaker animal health business and a strong euro weighing on the value of overseas sales. Sonia Legg reports.

  • We Are Optimistic for the Business Overall, Says Bayer CEO
    Bloomberg2 days ago

    We Are Optimistic for the Business Overall, Says Bayer CEO

    Nov.13 -- Werner Baumann, chief executive officer of Bayer AG, discusses the Monsanto acquisition, the value of the stock, shareholder confidence in the company and the possible sale of the animal health and consumer health divisions. He speaks exclusively on "Bloomberg Markets: European Open."

  • The Wall Street Journal2 days ago

    [$$] Bayer Hit by More Lawsuits Over Safety of Roundup Weedkiller

    BERLIN—Bayer AG disclosed another jump in the number of lawsuits alleging the German company’s recently acquired weedkillers cause cancer, elevating an issue that has wiped billions off Bayer’s market valuation. Lawsuits from 9,300 plaintiffs were pending at the end of October compared with 8,700 at the end of August, Bayer said Tuesday. Plaintiffs claim that Roundup weedkillers, which Bayer acquired in its takeover of Monsanto Co., made them ill and that Monsanto knew or should have known of the risks but failed to warn adequately.

  • Bayer (BAYRY) Beats on Q3 Earnings, Revenue Estimates
    Zacks2 days ago

    Bayer (BAYRY) Beats on Q3 Earnings, Revenue Estimates

    Bayer (BAYRY) surpasses earnings and sales estimates in the third quarter of 2018 and reiterates outlook for 2018.

  • Bayer Vows to Back Roundup as Investors Fret About Crop Unit
    Bloomberg2 days ago

    Bayer Vows to Back Roundup as Investors Fret About Crop Unit

    Bayer earlier reported adjusted earnings that beat analysts’ estimates but also disclosed a rising number of Roundup lawsuits. Bayer repeated that profit and sales will grow this year, even as its consumer health and animal businesses struggle.

  • The Wall Street Journal2 days ago

    [$$] European Equities Market Talk Roundup

    0944 GMT - Henkel’s topline looks “gloomy” ahead of the company’s third-quarter update but there’s hope its margin growth will improve, say analysts at Bernstein. Organic growth should slow to 2.9% due to tougher comparatives and additional headwinds in its adhesives unit, Bernstein says. “Specifically, we expect adhesives to slow to 4.3%, while laundry should decelerate slightly and beauty should be broadly stable,” Bernstein says.

  • The Wall Street Journal2 days ago

    [$$] Bayer Earnings Drop as Weedkiller Lawsuits Increase

    The German chemical and pharmaceutical group said 9,300 plaintiffs have now brought lawsuits over glyphosate-based weedkillers made by the recently acquired Monsanto group, compared with 8,700 at the end of August.

  • Ken Fisher Sells Berkshire, Bayer
    GuruFocus.com3 days ago

    Ken Fisher Sells Berkshire, Bayer

    The founder, executive chairman and co-chief investment officer of Fisher Investments, Ken Fisher (Trades, Portfolio), sold shares in the following stocks during the third quarter. Warning! GuruFocus has detected 4 Warning Sign with BRK.B. Click here to check it out. The guru almost closed his Berkshire Hathaway Inc. Class B (BRK.B) position after a reduction of 91.08%.

  • What's in the Cards for Bayer (BAYRY) This Earnings Season?
    Zacks3 days ago

    What's in the Cards for Bayer (BAYRY) This Earnings Season?

    Bayer (BAYRY) is scheduled to report third-quarter earnings on Nov 13. Acquisition of Mosanto is expected to boost sales of Crop Science segment significantly.

  • Investor's Business Daily9 days ago

    Regeneron Crushes Profit Views, But Cuts A Key Piece Of Its Outlook

    Regeneron Pharmaceuticals crushed Wall Street's third-quarter profit views by 66 cents, though sales of eye drug Eylea lagged outside the U.S.

  • Regeneron (REGN) Q3 Earnings Beat Estimates, Revenues In Line
    Zacks9 days ago

    Regeneron (REGN) Q3 Earnings Beat Estimates, Revenues In Line

    Regeneron (REGN) Q3 results beat on earnings, while sales meet expectations. However, the company's dependence on Eylea to boost revenues is a concern.

  • Bayer CEO says would consider glyphosate settlement depending on costs
    Reuters13 days ago

    Bayer CEO says would consider glyphosate settlement depending on costs

    Bayer AG's chief executive said this week the company might consider settling lawsuits over Monsanto's glyphosate-containing weed-killers depending on how high court costs rise, but stressed it remained focused on defending the combined company against claims they cause cancer. Bayer acquired Monsanto this year for $63 billion. "If we can settle nuisances at some point where the defense costs in preparing cases are higher than potential settlement amounts, we will of course consider it from an economic standpoint," CEO Werner Baumann told reporters when asked whether there was any scenario in which Bayer would consider settling.

  • Reuters13 days ago

    Bayer CEO says would consider glyphosate settlement depending on costs

    Bayer AG's (BAYGn.DE) chief executive said this week the company might consider settling lawsuits over Monsanto's glyphosate-containing weed-killers depending on how high court costs rise, but stressed it remained focussed on defending the combined company against claims they cause cancer. Bayer acquired Monsanto this year for $63 billion (£48.4 billion). "If we can settle nuisances at some point where the defence costs in preparing cases are higher than potential settlement amounts, we will of course consider it from an economic standpoint," CEO Werner Baumann told reporters when asked whether there was any scenario in which Bayer would consider settling.

  • The Wall Street Journal15 days ago

    [$$] EPA Allows Farmers to Keep Using Bayer’s Controversial Weedkiller

    The Environmental Protection Agency will continue to allow farmers to spray crops with a controversial weedkiller, while tightening restrictions, the agency said. The EPA extended by two years its approval of XtendiMax, a version of the herbicide dicamba made by Bayer AG, which some farmers and researchers have blamed for damaging millions of acres of crops over the past two years. The decision is a win for Bayer, which also markets soybean and cotton seeds genetically engineered to survive the chemical.

  • Reuters15 days ago

    EPA adds restrictions to use of Bayer, BASF weed killer linked to crop damage

    The U.S. Environmental Protection Agency said on Wednesday it would allow farmers to spray a controversial weed killer made by Bayer AG's Monsanto Co and BASF SE for two more years, with additional restrictions on use. The agency said the herbicide, called dicamba, is an important tool for controlling weeds in crop fields.

  • Groundskeeper accepts reduced $78 million Monsanto verdict
    Associated Press15 days ago

    Groundskeeper accepts reduced $78 million Monsanto verdict

    SAN FRANCISCO (AP) — A Northern California groundskeeper said Wednesday that he will accept a judge's reduced verdict of $78 million against Monsanto after a jury found the company's weed killer caused his cancer.

  • Reuters15 days ago

    Groundskeeper in Bayer in U.S. weed-killer case accepts reduced award

    The school groundskeeper who won a jury trial against Bayer AG's Monsanto unit over allegations that the company's glyphosate-containing weed-killers caused his cancer, accepted a court-mandated reduced punitive damages award on Wednesday. The decision by Dewayne Johnson, who sued Monsanto in 2016, brings the total award to $78 million, down from the jury's verdict on Aug. 10 of $289 million - $39 million in compensatory and $250 million in punitive damages. Judge Suzanne Bolanos of San Francisco's Superior Court of California, who oversaw the trial, earlier this month affirmed the liability portion of the verdict, but ordered punitive damages to be slashed to concur with California and federal law.

  • Reuters15 days ago

    EPA adds restrictions to use of controversial weed killer

    The U.S. Environmental Protection Agency said on Wednesday it would allow farmers to spray a controversial weed killer made by Bayer AG's Monsanto Co and BASF SE for two more years, with additional restrictions on use. Farmers have complained that the herbicide called dicamba drifts away after it is sprayed on soy and cotton plants that Monsanto engineered to resist it.

  • Reuters15 days ago

    EPA allows U.S. farmers to keep using weed killer linked to crop damage

    The U.S. Environmental Protection Agency said on Wednesday it would allow farmers to spray a controversial weed killer made by Bayer AG's Monsanto Co and BASF SE for another two years, with some additional ...

  • How Much Herbicide Can You Tolerate in Your Food, and for How Long?
    Bloomberg20 days ago

    How Much Herbicide Can You Tolerate in Your Food, and for How Long?

    From oatmeal to granola bars, ice cream to even orange juice, trace amounts of the chemical can be found throughout your local supermarket. Since then, it’s become a legal headache for Monsanto, and now Bayer AG, which bought the company in June for $66 billion. While regulators including the U.S. Environmental Protection Agency say the glyphosate found in food isn’t a problem because it’s at low levels, some scientists contend not enough is known about the effects of eating small amounts of it, especially over long periods of time.

  • Billionaire's Cotton Dream Languishes in Seed-Royalty Limbo
    Bloomberg21 days ago

    Billionaire's Cotton Dream Languishes in Seed-Royalty Limbo

    In Argentina, the latest patented cotton seeds available are at least a decade old. Using those in 2018 is “like running a Ferrari on compressed natural gas,” said David Hughes, agricultural adviser to Eurnekian’s holding company Corporacion America. The problem is that the South American country -- a farming powerhouse and the biggest exporter of soybean meal -- can’t decide how to update its intellectual property laws.

  • Billionaire's Cotton Dream Languishes in Seed-Royalty Limbo
    Bloomberg21 days ago

    Billionaire's Cotton Dream Languishes in Seed-Royalty Limbo

    In Argentina, the latest patented cotton seeds available are at least a decade old. Using those in 2018 is “like running a Ferrari on compressed natural gas,” said David Hughes, agricultural adviser to Eurnekian’s holding company Corporacion America. The problem is that the South American country -- a farming powerhouse and the biggest exporter of soybean meal -- can’t decide how to update its intellectual property laws.

  • The Wall Street Journal23 days ago

    [$$] Behind Bayer’s Tough Defense of Roundup

    Bayer has a history of fighting big-ticket litigation, which explains its approach to the thousands of lawsuits alleging Monsanto’s Roundup herbicide causes cancer.

  • Monsanto weed killer ruling is 1st step in long legal battle
    Associated Press23 days ago

    Monsanto weed killer ruling is 1st step in long legal battle

    SAN FRANCISCO (AP) — With its stock dropping and more lawsuits expected, Monsanto vowed Tuesday to press on with a nationwide legal defense of its best-selling weed killer Roundup after a San Francisco judge upheld a verdict alleging it causes cancer.